Tendencies and developments to be found in observations and warning letters.
Non-compliance issues tend to be on computerised systems and especially within issues on data integrity. This eventually documents, that regulatory authorities now are looking for e.g. data integrity non-compliance issues.
Medicines and Healthcare Products Regulatory Agency in the UK (MHRA) has published a GMP Data Integrity guideline (March 2015)
[amazon_link asins=’1118024303,1522021140,0198719795,1119240239,B01AS2T0ZA’ template=’ProductCarousel’ store=’digieboodown-21′ marketplace=’UK’ link_id=’5d5c766c-849a-11e7-bdc2-1b7420a1b569′]
Anna Lundén talks about tendencies and developments to be found in observations and warning letters